Evidence map›Paper›PMID 30510134›Full record

Observational studyJournal of the American Society of Nephrology : JASN2019

Sex-Related Disparities in CKD Progression.

Ana C Ricardo, Wei Yang, Daohang Sha, Lawrence J Appel, Jing Chen, Marie Krousel-Wood, Anjella Manoharan, Susan Steigerwalt, Jackson Wright, Mahboob Rahman and 6 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of the American Society of Nephrology : JASN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 185 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
185citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

185 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Authors' Reply: Interpreting Biomarker Adjustment in Sex-Associated CKD Risk.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  10. Review
  11. Sex differences in renal acid-base regulation.Current opinion in nephrology and hypertension · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Renal Tubule Cell-SpecificHypertension (Dallas, Tex. : 1979) · 2026
    Article
  17. Article
  18. Risk of Hospital Readmission among People with CKD: A Population-Based Cohort Study.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  19. Review
  20. Review

125 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Ana C RicardoDepartment of Medicine, Institute for Minority Health Research, University of Illinois at Chicago, Chicago, Illinois; aricar2@uic.edu.
Wei YangDepartments of Medicine and Epidemiology and Biostatistics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania.
Daohang ShaDepartments of Medicine and Epidemiology and Biostatistics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania.
Lawrence J AppelDepartment of Medicine, Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.
Jing ChenDepartments of Medicine and.
Marie Krousel-WoodDepartments of Medicine and.
Anjella ManoharanDepartment of Medicine, Institute for Minority Health Research, University of Illinois at Chicago, Chicago, Illinois.
Susan SteigerwaltDepartment of Medicine, University of Michigan, Ann Arbor, Michigan.
Jackson WrightDepartment of Medicine, Case Western University, University Hospitals Case Medical Center, Cleveland, Ohio.
Mahboob RahmanDepartment of Medicine, Case Western University, University Hospitals Case Medical Center, Cleveland, Ohio.
Sylvia E RosasDepartment of Medicine, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Milda SaundersDepartment of Medicine, University of Chicago, Chicago, Illinois; and.
Kumar SharmaDepartment of Medicine, University of California, San Diego, California.
Martha L DaviglusDepartment of Medicine, Institute for Minority Health Research, University of Illinois at Chicago, Chicago, Illinois.
James P LashDepartment of Medicine, Institute for Minority Health Research, University of Illinois at Chicago, Chicago, Illinois.
CRIC Investigators

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Scientific and Data Coordinating Center(SDCC) for the P*U01DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, HAROLD I · 2001 to 2017
$50.1M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1DUC4DK101108 · NIDDK · JOSLIN DIABETES CENTER · PI DORIA, ALESSANDRO, MAUER, S. MICHAEL · 2013 to 2018
$31.6M
Tulane COBRE in Cardiometabolic Diseases Clinical Research CoreP20GM109036 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI JING CHEN · 2016 to 2026
$25.3M
Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
Zonulin Antibodies in Intestinal Permeabilitiy in IDDMM01RR016500 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI OSWALD, LYNN M · 2002 to 2009
$20.2M
NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1 TR000424NCATS NIH HHS UL1 TR000433NCATS NIH HHS UL1 TR000439NCRR NIH HHS M01 RR016500NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1 RR029879NHLBI NIH HHS R01 HL127028NIDDK NIH HHS K23 DK094829NIDDK NIH HHS K24 DK092290NIDDK NIH HHS R01 DK072231NIDDK NIH HHS U01 DK060902NIDDK NIH HHS U01 DK060963NIDDK NIH HHS U01 DK060980NIDDK NIH HHS U01 DK060984NIDDK NIH HHS U01 DK060990NIDDK NIH HHS U01 DK061021NIDDK NIH HHS U01 DK061022NIDDK NIH HHS U01 DK061028NIDDK NIH HHS UC4 DK101108NIGMS NIH HHS P20 GM109036
6 · The paper itself

Abstract

backgroundIn the United States, incidence of ESRD is 1.5 times higher in men than in women, despite men's lower prevalence of CKD. Prior studies, limited by inclusion of small percentages of minorities and other factors, suggested that men have more rapid CKD progression, but this finding has been inconsistent.

methodsIn our prospective investigation of sex differences in CKD progression, we used data from 3939 adults (1778 women and 2161 men) enrolled in the Chronic Renal Insufficiency Cohort Study, a large, diverse CKD cohort. We evaluated associations between sex (women versus men) and outcomes, specifically incident ESRD (defined as undergoing dialysis or a kidney transplant), 50% eGFR decline from baseline, incident CKD stage 5 (eGFR<15 ml/min per 1.73 m

resultsParticipants' mean age was 58 years at study entry; 42% were non-Hispanic black, and 13% were Hispanic. During median follow-up of 6.9 years, 844 individuals developed ESRD, and 853 died. In multivariable regression models, compared with men, women had significantly lower risk of ESRD, 50% eGFR decline, progression to CKD stage 5, and death. The mean unadjusted eGFR slope was -1.09 ml/min per 1.73 m

conclusionsIn this CKD cohort, women had lower risk of CKD progression and death compared with men. Additional investigation is needed to identify biologic and psychosocial factors underlying these sex-related differences.

Indexed as

Cause of DeathDisease ProgressionHealth Status DisparitiesAdultAgedCohort StudiesFemaleGlomerular Filtration RateHumansKidney Failure, ChronicKidney Function TestsMaleMiddle AgedPrevalenceProspective StudiesRenal Dialysischronic kidney diseaseEpidemiology and outcomesESRDmortality risk

Identifiers

PMID30510134
PMCPMC6317604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.